Drug Profile
Capsaicin/Diclofenac - Boehringer Ingelheim
Alternative Names: Diclofenac/capsaicinLatest Information Update: 27 Oct 2020
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Class Analgesics; Anti-inflammatories; Catechols; Monounsaturated fatty acids; Non-opioid analgesics; Phenylacetates; Polyunsaturated alkamides; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Substance P inhibitors; TRPV1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute pain
Most Recent Events
- 27 Oct 2020 No development reported - Phase-III for Acute pain in Germany (Topical)
- 27 Oct 2020 No development reported - Phase-III for Acute pain in Russia (Topical)
- 28 Jan 2019 Chemical structure information added